Roche Molecular Diagnostics gained approval Oct. 5 from FDA for its cobas Zika virus test, a qualitative nucleic acid test indicated to detect Zika virus DNA in volunteer donors of whole blood, blood components, and plasma from living organ donors.
The approval follows up on an August 2016 guidance from the agency recommending that all states and territories in the...